Trials / Unknown
UnknownNCT03171805
The Use of Propranolol for the Prevention of Worsening of Esophageal Varices in Patients With Isolated Gastric Varices
Post-balloon Occluded Retrograde Transvenous Obliteration Use of Propranolol for the Prevention of Worsening of Esophageal Varices in Patients With Isolated Gastric Varices
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 74 (estimated)
- Sponsor
- West China Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
Balloon-occluded retrograde transvenous obliteration (BRTO) has been effective method to manage gastric varices. However, more than one third of patients after BRTO treatment experienced worsening of esophageal varices. The present study was designed to evaluate the effect of post-BRTO propranolol adminstration on the change of esophageal varices.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Propranolol | Propranolol was given after patients with cirrhosis and isolated gastric varices underwent balloon occluded retrograde transvenous obliteration successfully. |
Timeline
- Start date
- 2017-06-01
- Primary completion
- 2022-05-15
- Completion
- 2022-12-30
- First posted
- 2017-05-31
- Last updated
- 2021-11-23
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03171805. Inclusion in this directory is not an endorsement.